Viewing Study NCT06511193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-27 @ 10:38 AM
Study NCT ID: NCT06511193
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2024-07-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease (COPD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COPD; View
None readmissions; View
None maintenance therapy; View
None triple therapy; View
None real-world evidence; View
None mortality; View
None cardiopulmonary events, View
None exacerbations View